Physique Pharma CJC-1295 (with DAC) is a research-grade peptide supplied in sterile 3mL vials at a concentration of 5mg per vial. This peptide is widely studied in laboratory settings for its potential role in growth hormone regulation, tissue repair, and metabolic research.

CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone (GHRH) analog designed to extend half-life and improve stability, making it ideal for controlled experimental studies on hormone release, protein synthesis, and cellular regeneration.

Each vial is securely sealed to maintain sterility and ensure consistent, reliable use for research purposes.

Key Features:

• ⚗️ 5mg – 3mL vial for precise laboratory research applications.

• 💧 Sterile, research-grade peptide ensuring consistency and purity.

• 🔬 Supports studies on growth hormone release, tissue repair, and metabolic function.

• 🧴 Sealed vial maintains peptide stability and integrity.

• 🇦🇺 Australian supplied – trusted quality from Physique Pharma.

Intended Use:

CJC-1295 (with DAC) is intended for laboratory research purposes only. Typical applications include:

• Investigating growth hormone regulation and release mechanisms.

• Studying protein synthesis, tissue repair, and regenerative processes.

• Supporting advanced peptide research and experimental studies.

Not for human or animal use.

Physique Pharma – Delivering precision, purity, and reliability in peptide research.